© Hansa Medical

Marketing man

Hansa Medical, a Swedish biopharmaceutical company focusing on novel immunomodulatory enzymes, has appointed Henk Doude van Troostwijk as Vice President, Commercial Operations.

Doude van Troostwijk joins Hansa Medical from Raptor Pharmaceuticals, a US-based orphan drug developer, where he worked as General Manager of European Commercial Operations and Emerging Markets. Previously, he served as Business Unit Director Oncology and Transplantation at Genzyme.

Doude van Troostwijk holds an MBA from Henley Management College at the University of Reading, UK